Verde Science Investor Update
Las Vegas, NV -- March 13, 2015 -- InvestorsHub NewsWire --
(OTCPK:
VRCI) Verde Science, Inc., a Medical Research and Development
Company focused on developing effective treatments for emerging and
contemporary health issues, with an initial focus on Medical
Marijuana is pleased to update shareholders and investors regarding
significant developments in the Medical Marijuana R&D
arena.
Verde Science has firmly established its Research and
Development platform with research scientists, project directors,
and research institutions based in India, Canada and the U.S.; has
identified several initial promising R&D projects; and
completed its consolidated R&D and business plan.
“Achieving these critical steps clears the path for Verde to embark
on the development of specific pharmaceutical formulations based on
the marijuana plant, and enhances our ability to compete
effectively in the burgeoning Medical Marijuana field”, according
to Harp Sangha, Verde Science CEO.
“This is an especially timely development, as a landmark
bi-partison Medical Marijuana bill called the Compassionate Access,
Research Expansion and Respect States (CARERS) Act was introduced
in the U.S. Senate on March 10th. The bill would remove
federal penalties and restrictions for producing, distributing and
possessing marijuana for medical purposes. More important for Verde
Science is that the bill would eliminate current barriers to
research and development and recognize the acceptable medical use
of marijuana”, according to Louis Silver Verde Science Director of
Investor Relations. Among the bill’s sponsors are Senators Rand
Paul, Republican of Kentucky and Cory Booker, Democrat of New
Jersey.
Also, on Sunday, March 15th, 2015 at 8:30 pm EST Paul
Pelosi Jr. who is on VRCI’s Advisory Board, and Louis Silver
Managing Director of Investor Relations, will be appearing on the
popular internet radio show, Pot Stock radio, at http://potstockradio.com/pot-stock-radio-verde-science-force-fuels-wolf-weed-st-alan-brochstein/
About Verde Science, Inc. (VRCI)
Verde Science, Inc. (www.VerdeScienceInc.com) is a
public company trading under the symbol OTCPK:
VRCI. The Company is focused on Medical Marijuana
Research and Development, and providing advisory services, quality
assurance, and aeroponic growing systems in the burgeoning Medical
Marijuana industry to established, licensed growers throughout
Canada.
Safe Harbor Statements?Certain information contained in this
news release constitutes "forward-looking statements" as such term
is used in applicable United States and Canadian laws. Generally,
these forward-looking statements can be identified by the use of
forward-looking terminology such as "expects" or "does not expect",
"is expected", "anticipates" or "does not anticipate", "plans",
"estimates", "intends" or "believes", or that certain actions,
events or results "may", "could", "would", "might" or "will be
taken", "occur", or "be achieved". Forward-looking statements
are based on the opinions and estimates of management as of the
date such statements are made, and are subject to known and unknown
risks, uncertainties and other factors that may cause the actual
results, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements. Many of these factors are beyond the
Company's ability to control or predict. Important factors that may
cause actual results to differ materially and that could impact the
Company and the statements contained in this news release can be
found in the Company's filings with the SEC. Such risks and other
factors include, among others, the ability to locate and acquire
suitable interests in alternative medicine manufacturing operations
on terms acceptable to the Company, the availability of financing
on acceptable terms, accidents, labor disputes, acts of God and
other risks of the alternative medicine industry including, without
limitation, delays in obtaining governmental approvals or permits,
title disputes or claims limitations on insurance coverage. The
Company believes that the expectations reflected in the
forward-looking statements included in this news release are
reasonable; however, no assurance can be given that these
expectations will prove to be correct, and such forward-looking
statements should not be unduly relied upon. The Company assumes no
obligation to update or supplement any forward-looking statements
whether as a result of new information, future events or
otherwise.
For further information please contact:
Harp Sangha, Chairman/CEO
1-604-825-1309
harpsangha@shaw.ca
Louis Silver, Director of Investor Relations
1-610-710-1303
lsilver@verdescienceinc.com